Home NDC 53002-6430-3 Rifampin
Product NDC 53002-6430
Requested package NDC 53002-6430-3
11-digit product format 530026430
Labeler code 53002
Product ID 53002-6430_e6bcd207-0a10-4a55-b148-1c73d8da2acb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rifampin
Dosage form CAPSULE
Route ORAL
Labeler RPK Pharmaceuticals, Inc.
Application ANDA064150
Marketing category ANDA
Marketing start 1997-05-28
Marketing end 0000-00-00
Substance RIFAMPIN
Active strength 300 mg/1
Pharmacologic classes Rifamycin Antibacterial [EPC],Rifamycins [CS]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 17 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…2020-12-18 03:04 UTC · source 2020-12-17 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A064150-001 RIFAMPIN RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 A064150-002 RIFAMPIN RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A064150-001 RIFAMPIN 300MG CAPSULE / ORAL AB 1997-05-28 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A064150-002 RIFAMPIN 150MG CAPSULE / ORAL AB 1998-01-02 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 53002-6430-2 2023-01-30 Rifampin Capsules, USP 53002-6430-3 2023-01-30 Rifampin Capsules, USP 53002-6430-6 2023-01-30 Rifampin Capsules, USP 53002-6430-7 2023-01-30 Rifampin Capsules, USP 53002-6430-2 2020-12-17 Rifampin Capsules, USP 53002-6430-3 2020-12-17 Rifampin Capsules, USP 53002-6430-6 2020-12-17 Rifampin Capsules, USP 53002-6430-7 2020-12-17 Rifampin Capsules, USP 53002-6430-2 2020-01-31 Rifampin Capsules, USP 53002-6430-3 2020-01-31 Rifampin Capsules, USP 53002-6430-6 2020-01-31 Rifampin Capsules, USP 53002-6430-7 2020-01-31 Rifampin Capsules, USP
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 53002-6430-2 Rifampin 20 in 1 BOTTLE CAPSULE 20 3 53002-6430-3 Rifampin 30 in 1 BOTTLE CAPSULE 30 3 53002-6430-6 Rifampin 60 in 1 BOTTLE CAPSULE 60 3 53002-6430-7 Rifampin 70 in 1 BOTTLE CAPSULE 70 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 53002-6430 RIFAMPIN CAPSULE [RPK PHARMACEUTICALS, INC.] 3 Legacy NDC, 4 package rows 20201218_4905542c-83a5-4507-a7cf-94f827119c60.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 53002-6430-3 53002643003 30 CAPSULE in 1 BOTTLE (53002-6430-3) 30 capsule 2018-10-01 0000-00-00 No No Current